CYBERMED NEWS - Higher Medical Scientifc Information and Research

prostate cancer

  • Eating tomatoes reduces your prostate cancer risk

    facebook Share on Facebook
    Eating tomatoes reduces your prostate cancer risk image

    Prostate cancer is now the most prevalent, certainly in the West—but men can reduce their risk by eating tomatoes.

  • Late-night snacking could lead to breast or prostate cancer

    facebook Share on Facebook
    Late-night snacking could lead to breast or prostate cancer image

    Eating your last meal of the day earlier—and at least before 9pm—helps lower your risk of breast and prostate cancer. And if you do snack later than that, you'll get a similar protective effect if you wait two hours after eating before going to bed.

    When you eat is just as important as what you eat and can have just as big an impact on your health, say researchers from the Barcelona Institute for Global Health.

  • Standard hormone therapy makes prostate cancer life-threatening

    facebook Share on Facebook
    Standard hormone therapy makes prostate cancer life-threatening image

    A standard hormone treatment for prostate cancer can sometimes cause the cancer to spread or recur, researchers have found.

    Androgen-targeted therapy (ATT) is routinely used on the most common type of prostate cancer, adenocarcinoma, in its early stage. It targets androgens, the male sex hormones that can stimulate tumor growth—but sometimes the hormones become resistant to ATT and are transformed into a more dangerous type, neuroendocrine cancer cells.

  • The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors

    facebook Share on Facebook

    The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors

     

    Abstract

    We have recently reported that lowering the pH to values that are frequently detected in tumors causes reversible anergy in both human and mouse CD8+ T lymphocytes in vitro. The same occurs in vivo, in the tumor microenvironment and the administration of proton pump inhibitors, which buffer tumor acidity, can revert T-cell anergy and increase the efficacy of immunotherapy.

     

    https://www.ncbi.nlm.nih.gov/pubmed/23483769

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.